Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the nivolumab, idarubicin, and cytarabine study is available, with its study design, eligibility criteria, outcome measures, and supporting documents. It indicates that the study is completed and is no longer recruiting participants.
    Difference
    82%
    Check dated 2026-11-10T18:51:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T18:58:28.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, and the site revision identifier changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:34:25.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:50:37.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message with a minimal header and a Home link, replacing the previously loaded study details and navigation.
    Difference
    23%
    Check dated 2026-09-22T22:29:52.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-09-15T21:38:41.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.